US FDA approves AbbVie's drug for Parkinson's disease - Reuters
US FDA approves AbbVie's drug for Parkinson's disease Reuters
Related discussion groups
No group discusses this yet. Start a discussion group and attach this story.
More news about United States of America
- US Stock Futures Slip on Mounting Energy Shock, AI Bubble FearsUS stock futures are pointing to a lower open as investors weigh renewed energy-supply risks and persistent inflation pressures from AI-related capital spending that suggest the Federal Reserve may...
- AI Darlings, Defense Shares Most at Risk as US Midterms NearArtificial-intelligence regulation, along with government spending on healthcare and defense are emerging as equity investors’ chief points of focus as the final month of the US midterm campaign ki...
- How expanded Japan-US military exercises could complicate PLA planning over TaiwanJapan and the United States will rehearse moving anti-ship missiles, air defences and communications networks onto islands near Taiwan this month in an expanded military exercise that analysts say...
- Hegseth address sailors in pushup apology and Trump impressionUS Secretary of Defense Pete Hegseth did a ‘two pushup’ forfeit after factual errors addressing US sailors.
- AI Hot Potato Is Meta’s for Now, But Chip Stocks Are the WinnersWall Street pros say chipmakers remain the best way for equity investors to play the race for the top artificial intelligence agent even as Meta Platforms Inc.’s Muse seems to have seized the baton.
- Devon to Sell Shale Oil Assets to Crescent for $4.2 BillonDevon Energy Corp. agreed to sell its drilling portfolio in the Eagle Ford shale basin of South Texas to Crescent Energy Co., an oil producer backed by KKR & Co., for about $4.2 billion.
- Yardeni Sees Bond Yields Heading in ‘Danger Zone’ DirectionEdward Yardeni, president at Yardeni Research, discusses the factors pushing bond yields higher globally as he sees a “spectrum” of yield scenarios for the market. Yardeni finds US fiscal policy, n...
- US infant defies bleak odds from rare congenital trait: ‘Don’t quit before your child quits’Wren Michelle Roberts was born with heterotaxy, a syndrome so rare a specialist could only find 15 similar casesSouth-eastern Louisiana couple Nick and Savannah Roberts planned to bury their infant...